
Clinical Nutrition For Diabetes Care Market Report 2026
Global Outlook – By Product (Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas), By Stage (Adult, Pediatric), By Sales Channel (Online, Retail, Institutional Sales) - Market Size, Trends, And Global Forecast 2026-2035
Clinical Nutrition For Diabetes Care Market Overview
• Clinical Nutrition For Diabetes Care market size has reached to $3.17 billion in 2025 • Expected to grow to $4.44 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Diabetes Epidemic Fuels Growth of Clinical Nutrition Market • Market Trend: Specialized Diabetes Nutrition Products Support Blood Sugar Control And Overall Health • North America was the largest region in 2025.What Is Covered Under Clinical Nutrition For Diabetes Care Market?
Clinical nutrition for diabetes care refers to offering specialized dietary guidance and nutritional support to individuals managing diabetes. It encompasses personalized assessments, meal planning, and education on carbohydrate management, glycemic control, and lifestyle modifications. The primary aim is to optimize nutrition, regulate blood sugar levels, prevent complications, and enhance overall health outcomes for those with diabetes. The main products of clinical nutrition for diabetes care are oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition in the clinical nutrition for diabetes care market refers to dietary supplements, drinks, or foods consumed by mouth to meet the nutritional needs of individuals with diabetes, aiming to manage blood sugar levels effectively. They are used for various stages of patients of adult and pediatrics and are distributed by various channels including online, retail, and institutional sales.
What Is The Clinical Nutrition For Diabetes Care Market Size and Share 2026?
The clinical nutrition for diabetes care market size has grown strongly in recent years. It will grow from $3.17 billion in 2025 to $3.42 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing prevalence of diabetes worldwide, expansion of diabetes management programs, rising awareness of nutritional therapy in diabetes care, growth in institutional nutrition services, availability of specialized diabetic nutrition products.What Is The Clinical Nutrition For Diabetes Care Market Growth Forecast?
The clinical nutrition for diabetes care market size is expected to see strong growth in the next few years. It will grow to $4.44 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing focus on personalized diabetes management, rising adoption of low-carbohydrate and fiber-enriched nutrition, expansion of remote patient monitoring solutions, growing integration of nutrition with digital diabetes care platforms, increasing demand for preventive nutrition strategies. Major trends in the forecast period include increasing adoption of personalized diabetes nutrition programs, rising demand for diabetic-specific oral and enteral formulas, growing use of digital nutrition monitoring tools, expansion of home-based diabetes nutrition management, enhanced focus on glycemic-control-oriented nutrition.Global Clinical Nutrition For Diabetes Care Market Segmentation
1) By Product: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas 2) By Stage: Adult, Pediatric 3) By Sales Channel: Online, Retail, Institutional Sales Subsegments: 1) By Oral Nutrition: Oral Nutritional Supplements (ONS), Diabetic-Specific Oral Nutritional Drinks, Protein-Rich Oral Supplements, Carbohydrate-Controlled Oral Supplements, Fiber-Enriched Oral Nutrition 2) By Parenteral Nutrition: Amino Acid Solutions For Diabetes, Glucose And Electrolyte Solutions, Lipid Emulsions For Parenteral Nutrition, Micronutrient Infusions For Diabetes, Insulin-Infused Parenteral Nutrition 3) By Enteral Feeding Formulas: Standard Enteral Formulas, Diabetic-Specific Enteral Formulas, High-Protein Enteral Feeding Formulas, Low-Carbohydrate Enteral Formulas, Fiber-Enriched Enteral Formulas, Modular Feeding SolutionsWhat Is The Driver Of The Clinical Nutrition For Diabetes Care Market?
The increase in the prevalence of diabetes is expected to propel the growth of the clinical nutrition for diabetes care market going forward. Diabetes is a group of metabolic disorders characterized by high blood sugar levels over a prolonged period, resulting from either inadequate insulin production or the body's ineffective use of insulin. The prevalence of diabetes is driven by factors such as sedentary lifestyles, unhealthy diets, genetic predisposition, and aging populations. Clinical nutrition for diabetes care is crucial in helping diabetes patients to manage their condition by providing tailored dietary plans that regulate blood sugar levels, promote weight management, and reduce the risk of complications. For instance, in June 2024, according to the National Health Service (NHS), UK-based government department, among individuals under 40, rising from 173,166 in 2022 to 216,440 in 2023. This significant growth highlights a concerning trend in this age group. The data reflects a rapid escalation in diabetes prevalence among younger populations. Therefore, the increase in the prevalence of diabetes is driving the growth of the clinical nutrition for diabetes care industry.Key Players In The Global Clinical Nutrition For Diabetes Care Market
Major companies operating in the clinical nutrition for diabetes care market are Pfizer Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Roche Holdings Inc., Medtronic plc, Danone SA, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd, Baxter International Inc., B. Braun Melsungen AG, Glanbia plc, Perrigo Company plc, MannKind Corp, Omada Health, Fresenius Kabi AG, Hormel Health Labs Inc, Kate Farms Inc, Meiji Holdings Co Ltd, Otsuka Holdings Co Ltd, Herbalife Nutrition LtdGlobal Clinical Nutrition For Diabetes Care Market Trends and Insights
Major companies operating in the clinical nutrition for diabetes care market are developing specialized nutritional formulations to address the specific dietary needs of diabetes patients, including managing blood sugar levels and supporting overall health. Specialized nutrition provides balanced nutrition, controls blood sugar levels, and promotes overall health in diabetes patients. For instance, in March 2024, Abbott Healthcare Pvt Ltd., a US-based pharmaceutical manufacturer, launched its nutritional supplement drink for people with diabetes, Ensure Diabetes Care. Ensure Diabetes Care is a specialized nutritional supplement designed specifically for individuals managing diabetes. Ensure Diabetes Care is scientifically formulated with a low glycemic index and contains a blend of high-quality protein, complex carbohydrates, dietary fiber, and essential vitamins and minerals.What Are Latest Mergers And Acquisitions In The Clinical Nutrition For Diabetes Care Market?
In June 2023, Abbott Laboratories, a US-based medical devices and healthcare company that offers specialized nutritional products, partnered with the American Diabetes Association (ADA). Through this partnership, Abbott Laboratories and the American Diabetes Association (ADA) aim to pioneer innovative solutions for diabetes management and care. They develop cutting-edge technologies, educational resources, and support systems to empower individuals living with diabetes. The American Diabetes Association (ADA) is a US-based nonprofit organization that seeks to educate the public about diabetes.Regional Outlook
North America was the largest region in the clinical nutrition for diabetes care market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Clinical Nutrition For Diabetes Care Market?
The clinical nutrition for diabetes care market consists of revenues earned by entities by providing services such as medical nutrition therapy, dietary counseling, and diabetes self-management education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical nutrition for diabetes care market also includes sales of oral nutrition supplements, enteral nutrition, glucose control formulas, and low-glycemic index foods. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Clinical Nutrition For Diabetes Care Market Report 2026?
The clinical nutrition for diabetes care market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition for diabetes care industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Clinical Nutrition For Diabetes Care Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $3.42 billion |
| Revenue Forecast In 2035 | $4.44 billion |
| Growth Rate | CAGR of 8.0% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Stage, Sales Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Pfizer Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Roche Holdings Inc., Medtronic plc, Danone SA, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd, Baxter International Inc., B. Braun Melsungen AG, Glanbia plc, Perrigo Company plc, MannKind Corp, Omada Health, Fresenius Kabi AG, Hormel Health Labs Inc, Kate Farms Inc, Meiji Holdings Co Ltd, Otsuka Holdings Co Ltd, Herbalife Nutrition Ltd |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
